| Package | dk.kip.rkkp.fhir.ig.core |
| Type | CodeSystem |
| Id | Id |
| FHIR Version | R4 |
| Source | https://kip.rkkp.dk/fhir/https://build.fhir.org/ig/KIP-infrastructure/implementation-guide/CodeSystem-ATC.html |
| Url | https://kip.rkkp.dk/fhir/CodeSystem/ATC |
| Version | 2.11.6 |
| Status | active |
| Date | 2022-06-14T00:00:00+02:00 |
| Name | ATC |
| Title | WHO ATC |
| Experimental | False |
| Description | WHO ATC code system. Link: http://www.whocc.no/atc |
| Content | fragment |
| ValueSet | |
ATCAntibiotikaprofylakseDKR  | ATC - Antibiotikaprofylakse (DKR) |
| ATCChemoCLL | ATC_CLL_kemo |
| ATCChemoPreparation | ATC: Præparater for kemobehandling |
| ATCDMPN | ATC DMPN |
| ATCDMPN202410 | ATC DMPN 202410 |
| ATCImmunotherapyCLL | ATC_CLL_immunterapi |
| ATCTargetCLL | ATC_CLL_target |
| ATCTromboseprofylakseDKR | ATC - Tromboseprofylakse (DKR) |
| AntibiotikaprofylakseDHR | Antibiotikaprofylakse (DHR) |
| AntibiotikaprofylakseDKRR | Antibiotikaprofylakse (DKRR) |
| BehandlingCML | Behandling (CML) |
| BehandlingCMMLMDS | Behandlinger foretaget i forbindelse med CMML (MDS) |
| BehandlingMDS | Behandlinger foretaget i forbindelse med MDS (MDS) |
| BehandlingsTypeStamcellestoetteLYFO | Behandlingsttype - Stamcellestøtte (LYFO) |
| BloedningsprofylakseDHR | Blødningsprofylakse (DHR) |
| Immunoterapi | Immunoterapi |
| Kemoterapiregime | Kemoterapiregime |
| Radioimmunoterapi | Radioimmunoterapi |
| TreatmentPreservation | Vedligeholdelsesbehandling |
| TreatmentScheduledDAMYDA | Planlagt behandling (DAMYDA) |
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: CodeSystem ATC
This case-sensitive code system https://kip.rkkp.dk/fhir/CodeSystem/ATC provides a fragment that includes following codes in an undefined hierarchy:
FHIR{
"resourceType" : "CodeSystem",
"id" : "ATC",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem ATC</b></p><a name=\"ATC\"> </a><a name=\"hcATC\"> </a><p>This case-sensitive code system <code>https://kip.rkkp.dk/fhir/CodeSystem/ATC</code> provides <b>a fragment</b> that includes following codes in an undefined hierarchy:</p><table class=\"codes\"><tr><td><b>Lvl</b></td><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td>1</td><td style=\"white-space:nowrap\">B01A<a name=\"ATC-B01A\"> </a></td><td>ANTITHROMBOTIC AGENTS</td><td>B01A - ANTITHROMBOTIC AGENTS</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��B01AA03<a name=\"ATC-B01AA03\"> </a></td><td>warfarin</td><td>B01AA03 - warfarin</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��B01AB01<a name=\"ATC-B01AB01\"> </a></td><td>heparin</td><td>B01AB01 - heparin</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��B01AB04<a name=\"ATC-B01AB04\"> </a></td><td>dalteparin</td><td>B01AB04 - dalteparin</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��B01AB05<a name=\"ATC-B01AB05\"> </a></td><td>enoxaparin</td><td>B01AB05 - enoxaparin</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��B01AB10<a name=\"ATC-B01AB10\"> </a></td><td>tinzaparin</td><td>B01AB10 - tinzaparin</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��B01AC06<a name=\"ATC-B01AC06\"> </a></td><td>acetylsalicylic acid</td><td>B01AC06 - acetylsalicylic acid</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��B01AE07<a name=\"ATC-B01AE07\"> </a></td><td>dabigatran etexilate</td><td>B01AE07 - dabigatran etexilate</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��B01AF01<a name=\"ATC-B01AF01\"> </a></td><td>rivaroxaban</td><td>B01AF01 - rivaroxaban</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��B01AF02<a name=\"ATC-B01AF02\"> </a></td><td>apixaban</td><td>B01AF02 - apixaban</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��B01AX05<a name=\"ATC-B01AX05\"> </a></td><td>fondaparinux</td><td>B01AX05 - fondaparinux</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">B02AA02<a name=\"ATC-B02AA02\"> </a></td><td>tranexamic acid</td><td>B02AA02 - Tranexamic acid</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">B03XA01<a name=\"ATC-B03XA01\"> </a></td><td>erythropoietin</td><td>B03XA01 - erythropoietin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">C10AA<a name=\"ATC-C10AA\"> </a></td><td>HMG CoA reductase inhibitors</td><td>C10AA - HMG CoA reductase inhibitors</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">H02<a name=\"ATC-H02\"> </a></td><td>CORTICOSTEROIDS FOR SYSTEMIC USE</td><td>H02 - CORTICOSTEROIDS FOR SYSTEMIC USE</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">J01CF01<a name=\"ATC-J01CF01\"> </a></td><td>dicloxacillin</td><td>J01CF01 - dicloxacillin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">J01CF02<a name=\"ATC-J01CF02\"> </a></td><td>cloxacillin</td><td>J01CF02 - cloxacillin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">J01CF03<a name=\"ATC-J01CF03\"> </a></td><td>meticillin</td><td>J01CF03 - meticillin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">J01CF05<a name=\"ATC-J01CF05\"> </a></td><td>flucloxacillin</td><td>J01CF05 - flucloxacillin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">J01DB01<a name=\"ATC-J01DB01\"> </a></td><td>cefalexin</td><td>J01DB01 - cefalexin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">J01DB03<a name=\"ATC-J01DB03\"> </a></td><td>cefalotin</td><td>J01DB03 - cefalotin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">J01DC02<a name=\"ATC-J01DC02\"> </a></td><td>cefuroxime</td><td>J01DC02 - cefuroxime</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">J01FA01<a name=\"ATC-J01FA01\"> </a></td><td>erythromycin</td><td>J01FA01 - erythromycin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">J01GB03<a name=\"ATC-J01GB03\"> </a></td><td>gentamicin</td><td>J01GB03 - gentamicin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">J01XA01<a name=\"ATC-J01XA01\"> </a></td><td>vancomycin</td><td>J01XA01 - vancomycin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01AA01<a name=\"ATC-L01AA01\"> </a></td><td>cyclophosphamide</td><td>L01AA01 - cyclophosphamide</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01AA02<a name=\"ATC-L01AA02\"> </a></td><td>chlorambucil</td><td>L01AA02 - chlorambucil</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01AA03<a name=\"ATC-L01AA03\"> </a></td><td>melphalan</td><td>L01AA03 - melphalan</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01AA06<a name=\"ATC-L01AA06\"> </a></td><td>ifosfamide</td><td>L01AA06 - ifosfamide</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01AA09<a name=\"ATC-L01AA09\"> </a></td><td>bendamustine</td><td>L01AA09 - bendamustine</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01AB01<a name=\"ATC-L01AB01\"> </a></td><td>busulfan</td><td>L01AB01 - busulfan</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01AC01<a name=\"ATC-L01AC01\"> </a></td><td>thiotepa</td><td>L01AC01 thiotepa</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01AD01<a name=\"ATC-L01AD01\"> </a></td><td>carmustine</td><td>L01AD01 - carmustine</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01AX03<a name=\"ATC-L01AX03\"> </a></td><td>temozolomide</td><td>L01AX03 - temozolomide</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01AX04<a name=\"ATC-L01AX04\"> </a></td><td>dacarbazine</td><td>L01AX04 - dacarbazine</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01BB05<a name=\"ATC-L01BB05\"> </a></td><td>fludarabine</td><td>L01BB05 - fludarabine</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01BC02<a name=\"ATC-L01BC02\"> </a></td><td>fluorouracil</td><td>L01BC02 - Fluorouracil (5-FU)</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01BC05<a name=\"ATC-L01BC05\"> </a></td><td>gemcitabine</td><td>L01BC02 - Gemcitabine</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01BC06<a name=\"ATC-L01BC06\"> </a></td><td>capecitabine</td><td>L01BC06 - Capecitabine</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01BC07<a name=\"ATC-L01BC07\"> </a></td><td>azacitidine</td><td>L01BC07 - azacitidine</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01CA02<a name=\"ATC-L01CA02\"> </a></td><td>vincristine</td><td>L01CA02 - vincristine</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01CA04<a name=\"ATC-L01CA04\"> </a></td><td>vinorelbine</td><td>L01CA04 - Vinorelbine</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01CB01<a name=\"ATC-L01CB01\"> </a></td><td>etoposide</td><td>L01CB01 - etoposide</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01CD01<a name=\"ATC-L01CD01\"> </a></td><td>paclitaxel</td><td>L01CD01 - Paclitaxel</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01CD02<a name=\"ATC-L01CD02\"> </a></td><td>docetaxel</td><td>L01CD02 - Docetaxel</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01CE02<a name=\"ATC-L01CE02\"> </a></td><td>irinotecan</td><td>L01CE02 - Irinotecan</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01DB01<a name=\"ATC-L01DB01\"> </a></td><td>doxorubicin</td><td>L01DB01 - Doxorubicin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01DB03<a name=\"ATC-L01DB03\"> </a></td><td>epirubicin</td><td>L01DB03 - Epirubicin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01DB07<a name=\"ATC-L01DB07\"> </a></td><td>mitoxantrone</td><td>L01DB07 - mitoxantrone</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01DB11<a name=\"ATC-L01DB11\"> </a></td><td>pixantrone</td><td>L01DB11 - pixantrone</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01DC01<a name=\"ATC-L01DC01\"> </a></td><td>bleomycin</td><td>L01DC01 - bleomycin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01EA<a name=\"ATC-L01EA\"> </a></td><td>BCR-ABL tyrosine kinase inhibitors</td><td/></tr><tr><td>2</td><td style=\"white-space:nowrap\">��L01EA01<a name=\"ATC-L01EA01\"> </a></td><td>imatinib</td><td>L01EA01 - imatinib</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��L01EA02<a name=\"ATC-L01EA02\"> </a></td><td>dasatinib</td><td>L01EA02 - dasatinib</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��L01EA03<a name=\"ATC-L01EA03\"> </a></td><td>nilotinib</td><td>L01EA03 - nilotinib</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��L01EA04<a name=\"ATC-L01EA04\"> </a></td><td>bosutinib</td><td>L01EA04 - bosutinib</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��L01EA05<a name=\"ATC-L01EA05\"> </a></td><td>ponatinib</td><td>L01EA05 - ponatinib</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��L01EA06<a name=\"ATC-L01EA06\"> </a></td><td>Asciminib</td><td>L01EA06 - Asciminib</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01EB<a name=\"ATC-L01EB\"> </a></td><td>Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors</td><td>L01EB - Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01EH<a name=\"ATC-L01EH\"> </a></td><td>Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors</td><td>L01EH - Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01EJ<a name=\"ATC-L01EJ\"> </a></td><td>Janus-associated kinase (JAK) inhibitors</td><td>Janus associerede kinase (JAK) hæmmere</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��L01EJ01<a name=\"ATC-L01EJ01\"> </a></td><td>ruxolitinib</td><td>L01EJ01 - ruxolitinib</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01EK<a name=\"ATC-L01EK\"> </a></td><td>Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors</td><td>L01EK - Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01EL01<a name=\"ATC-L01EL01\"> </a></td><td>ibrutinib</td><td>L01EL01 - ibrutinib</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01EL02<a name=\"ATC-L01EL02\"> </a></td><td>acalabrutinib</td><td>L01EL02 - acalabrutinib</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01EM01<a name=\"ATC-L01EM01\"> </a></td><td>idelalisib</td><td>L01EM01 - idelalisib</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01EN<a name=\"ATC-L01EN\"> </a></td><td>Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors</td><td>L01EN - Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01FA01<a name=\"ATC-L01FA01\"> </a></td><td>rituximab</td><td>L01FA01 - rituximab</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01FA02<a name=\"ATC-L01FA02\"> </a></td><td>ofatumumab</td><td>L01FA02 - ofatumumab</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01FA03<a name=\"ATC-L01FA03\"> </a></td><td>obinutuzumab</td><td>L01FA03 - obinutuzumab</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01FC01<a name=\"ATC-L01FC01\"> </a></td><td>daratumumab</td><td>L01FC01 - daratumumab</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01FC02<a name=\"ATC-L01FC02\"> </a></td><td>isatuximab</td><td>L01FC02 - isatuximab</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01FD01<a name=\"ATC-L01FD01\"> </a></td><td>trastuzumab</td><td>L01FD01 - Trastuzumab</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01FF<a name=\"ATC-L01FF\"> </a></td><td>PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors</td><td>L01FF - PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��L01FF01<a name=\"ATC-L01FF01\"> </a></td><td>nivolumab</td><td>L01FF01 - Nivolumab</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��L01FF02<a name=\"ATC-L01FF02\"> </a></td><td>pembrolizumab</td><td>L01FF02 - Pembrolizumab</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01FG01<a name=\"ATC-L01FG01\"> </a></td><td>bevacizumab</td><td>L01FG01 - Bevacizumab</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01FX05<a name=\"ATC-L01FX05\"> </a></td><td>brentuximab vedotin</td><td>L01FX05 - brentuximab vedotin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01FX08<a name=\"ATC-L01FX08\"> </a></td><td>elotuzumab</td><td>L01FX08 - elotuzumab</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01FX14<a name=\"ATC-L01FX14\"> </a></td><td>polatuzumab vedotin</td><td>L01FX14 - polatuzumab vedotin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01XA01<a name=\"ATC-L01XA01\"> </a></td><td>cisplatin</td><td>L01XA01 - Cisplatin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01XA02<a name=\"ATC-L01XA02\"> </a></td><td>carboplatin</td><td>L01XA02 - Carboplatin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01XA03<a name=\"ATC-L01XA03\"> </a></td><td>oxaliplatin</td><td>L01XA03 - Oxaliplatin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01XG01<a name=\"ATC-L01XG01\"> </a></td><td>bortezomib</td><td>L01XG01 - bortezomib</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01XG02<a name=\"ATC-L01XG02\"> </a></td><td>carfilzomib</td><td>L01XG02 - carfilzomib</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01XG03<a name=\"ATC-L01XG03\"> </a></td><td>ixazomib</td><td>L01XG03 - ixazomib</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01XH<a name=\"ATC-L01XH\"> </a></td><td>Histone deacetylase (HDAC) inhibitors</td><td>L01XH - Histone deacetylase (HDAC) inhibitors</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��L01XH01<a name=\"ATC-L01XH01\"> </a></td><td>vorinostat</td><td>L01XH01 - vorinostat</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��L01XH03<a name=\"ATC-L01XH03\"> </a></td><td>panobinostat</td><td>L01XH03 - panobinostat</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01XX05<a name=\"ATC-L01XX05\"> </a></td><td>hydroxycarbamide</td><td>L01XX05 - hydroxycarbamide</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01XX35<a name=\"ATC-L01XX35\"> </a></td><td>anagrelide</td><td>L01XX35 - anagrelide</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01XX52<a name=\"ATC-L01XX52\"> </a></td><td>venetoclax</td><td>L01XX52 - venetoclax</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L03AB<a name=\"ATC-L03AB\"> </a></td><td>Interferons</td><td>L03AB - Interferons</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L04A<a name=\"ATC-L04A\"> </a></td><td>IMMUNOSUPPRESSANTS</td><td>L04A - IMMUNOSUPPRESSANTS</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��L04AA<a name=\"ATC-L04AA\"> </a></td><td>Selective immunosuppressants</td><td>L04AA - Selective immunosuppressants</td></tr><tr><td>3</td><td style=\"white-space:nowrap\">����L04AA34<a name=\"ATC-L04AA34\"> </a></td><td>alemtuzumab</td><td>L04AA34 - alemtuzumab</td></tr><tr><td>3</td><td style=\"white-space:nowrap\">����L04AA40<a name=\"ATC-L04AA40\"> </a></td><td>cladribine</td><td>L04AA40 - cladribine</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L04AD01<a name=\"ATC-L04AD01\"> </a></td><td>ciclosporin</td><td>L04AD01 - ciclosporin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L04AX02<a name=\"ATC-L04AX02\"> </a></td><td>thalidomide</td><td>L04AX02 - thalidomide</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L04AX04<a name=\"ATC-L04AX04\"> </a></td><td>lenalidomide</td><td>L04AX04 - lenalidomide</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L04AX06<a name=\"ATC-L04AX06\"> </a></td><td>pomalidomide</td><td>L04AX06 - pomalidomide</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">M05BA03<a name=\"ATC-M05BA03\"> </a></td><td>pamidronic acid</td><td>M05BA03 - pamidronic acid</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">M05BA08<a name=\"ATC-M05BA08\"> </a></td><td>zoledronic acid</td><td>M05BA08 - zoledronic acid</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">M05BX04<a name=\"ATC-M05BX04\"> </a></td><td>denosumab</td><td>M05BX04 - denosumab</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">S01LA08<a name=\"ATC-S01LA08\"> </a></td><td>bevacizumab</td><td>S01LA08 - Bevacizumab</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">V10X<a name=\"ATC-V10X\"> </a></td><td>OTHER THERAPEUTIC RADIOPHARMACEUTICALS</td><td>V10X - OTHER THERAPEUTIC RADIOPHARMACEUTICALS</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��V10XA53<a name=\"ATC-V10XA53\"> </a></td><td>tositumomab/iodine (131I) tositumomab</td><td>V10XA53 - tositumomab/iodine (131I) tositumomab</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��V10XX02<a name=\"ATC-V10XX02\"> </a></td><td>ibritumomab tiuxetan (90Y)</td><td>V10XX02 - ibritumomab tiuxetan (90Y)</td></tr></table></div>"
},
"url" : "https://kip.rkkp.dk/fhir/CodeSystem/ATC",
"identifier" : [
{
"value" : "urn:oid:2.16.840.1.113883.6.73"
}
],
"version" : "2.11.6",
"name" : "ATC",
"title" : "WHO ATC",
"status" : "active",
"date" : "2022-06-14T00:00:00+02:00",
"publisher" : "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S",
"contact" : [
{
"name" : "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S",
"telecom" : [
{
"system" : "url",
"value" : "https://trifork.com"
},
{
"system" : "email",
"value" : "rbk@trifork.com"
}
]
}
],
"description" : "WHO ATC code system. Link: http://www.whocc.no/atc",
"caseSensitive" : true,
"content" : "fragment",
"concept" : [
{
"code" : "B01A",
"display" : "ANTITHROMBOTIC AGENTS",
"definition" : "B01A - ANTITHROMBOTIC AGENTS",
"concept" : [
{
"code" : "B01AA03",
"display" : "warfarin",
"definition" : "B01AA03 - warfarin"
},
{
"code" : "B01AB01",
"display" : "heparin",
"definition" : "B01AB01 - heparin"
},
{
"code" : "B01AB04",
"display" : "dalteparin",
"definition" : "B01AB04 - dalteparin"
},
{
"code" : "B01AB05",
"display" : "enoxaparin",
"definition" : "B01AB05 - enoxaparin"
},
{
"code" : "B01AB10",
"display" : "tinzaparin",
"definition" : "B01AB10 - tinzaparin"
},
{
"code" : "B01AC06",
"display" : "acetylsalicylic acid",
"definition" : "B01AC06 - acetylsalicylic acid"
},
{
"code" : "B01AE07",
"display" : "dabigatran etexilate",
"definition" : "B01AE07 - dabigatran etexilate"
},
{
"code" : "B01AF01",
"display" : "rivaroxaban",
"definition" : "B01AF01 - rivaroxaban"
},
{
"code" : "B01AF02",
"display" : "apixaban",
"definition" : "B01AF02 - apixaban"
},
{
"code" : "B01AX05",
"display" : "fondaparinux",
"definition" : "B01AX05 - fondaparinux"
}
]
},
{
"code" : "B02AA02",
"display" : "tranexamic acid",
"definition" : "B02AA02 - Tranexamic acid"
},
{
"code" : "B03XA01",
"display" : "erythropoietin",
"definition" : "B03XA01 - erythropoietin"
},
{
"code" : "C10AA",
"display" : "HMG CoA reductase inhibitors",
"definition" : "C10AA - HMG CoA reductase inhibitors"
},
{
"code" : "H02",
"display" : "CORTICOSTEROIDS FOR SYSTEMIC USE",
"definition" : "H02 - CORTICOSTEROIDS FOR SYSTEMIC USE"
},
{
"code" : "J01CF01",
"display" : "dicloxacillin",
"definition" : "J01CF01 - dicloxacillin"
},
{
"code" : "J01CF02",
"display" : "cloxacillin",
"definition" : "J01CF02 - cloxacillin"
},
{
"code" : "J01CF03",
"display" : "meticillin",
"definition" : "J01CF03 - meticillin"
},
{
"code" : "J01CF05",
"display" : "flucloxacillin",
"definition" : "J01CF05 - flucloxacillin"
},
{
"code" : "J01DB01",
"display" : "cefalexin",
"definition" : "J01DB01 - cefalexin"
},
{
"code" : "J01DB03",
"display" : "cefalotin",
"definition" : "J01DB03 - cefalotin"
},
{
"code" : "J01DC02",
"display" : "cefuroxime",
"definition" : "J01DC02 - cefuroxime"
},
{
"code" : "J01FA01",
"display" : "erythromycin",
"definition" : "J01FA01 - erythromycin"
},
{
"code" : "J01GB03",
"display" : "gentamicin",
"definition" : "J01GB03 - gentamicin"
},
{
"code" : "J01XA01",
"display" : "vancomycin",
"definition" : "J01XA01 - vancomycin"
},
{
"code" : "L01AA01",
"display" : "cyclophosphamide",
"definition" : "L01AA01 - cyclophosphamide"
},
{
"code" : "L01AA02",
"display" : "chlorambucil",
"definition" : "L01AA02 - chlorambucil"
},
{
"code" : "L01AA03",
"display" : "melphalan",
"definition" : "L01AA03 - melphalan"
},
{
"code" : "L01AA06",
"display" : "ifosfamide",
"definition" : "L01AA06 - ifosfamide"
},
{
"code" : "L01AA09",
"display" : "bendamustine",
"definition" : "L01AA09 - bendamustine"
},
{
"code" : "L01AB01",
"display" : "busulfan",
"definition" : "L01AB01 - busulfan"
},
{
"code" : "L01AC01",
"display" : "thiotepa",
"definition" : "L01AC01 thiotepa"
},
{
"code" : "L01AD01",
"display" : "carmustine",
"definition" : "L01AD01 - carmustine"
},
{
"code" : "L01AX03",
"display" : "temozolomide",
"definition" : "L01AX03 - temozolomide"
},
{
"code" : "L01AX04",
"display" : "dacarbazine",
"definition" : "L01AX04 - dacarbazine"
},
{
"code" : "L01BB05",
"display" : "fludarabine",
"definition" : "L01BB05 - fludarabine"
},
{
"code" : "L01BC02",
"display" : "fluorouracil",
"definition" : "L01BC02 - Fluorouracil (5-FU)"
},
{
"code" : "L01BC05",
"display" : "gemcitabine",
"definition" : "L01BC02 - Gemcitabine"
},
{
"code" : "L01BC06",
"display" : "capecitabine",
"definition" : "L01BC06 - Capecitabine"
},
{
"code" : "L01BC07",
"display" : "azacitidine",
"definition" : "L01BC07 - azacitidine"
},
{
"code" : "L01CA02",
"display" : "vincristine",
"definition" : "L01CA02 - vincristine"
},
{
"code" : "L01CA04",
"display" : "vinorelbine",
"definition" : "L01CA04 - Vinorelbine"
},
{
"code" : "L01CB01",
"display" : "etoposide",
"definition" : "L01CB01 - etoposide"
},
{
"code" : "L01CD01",
"display" : "paclitaxel",
"definition" : "L01CD01 - Paclitaxel"
},
{
"code" : "L01CD02",
"display" : "docetaxel",
"definition" : "L01CD02 - Docetaxel"
},
{
"code" : "L01CE02",
"display" : "irinotecan",
"definition" : "L01CE02 - Irinotecan"
},
{
"code" : "L01DB01",
"display" : "doxorubicin",
"definition" : "L01DB01 - Doxorubicin"
},
{
"code" : "L01DB03",
"display" : "epirubicin",
"definition" : "L01DB03 - Epirubicin"
},
{
"code" : "L01DB07",
"display" : "mitoxantrone",
"definition" : "L01DB07 - mitoxantrone"
},
{
"code" : "L01DB11",
"display" : "pixantrone",
"definition" : "L01DB11 - pixantrone"
},
{
"code" : "L01DC01",
"display" : "bleomycin",
"definition" : "L01DC01 - bleomycin"
},
{
"code" : "L01EA",
"display" : "BCR-ABL tyrosine kinase inhibitors",
"concept" : [
{
"code" : "L01EA01",
"display" : "imatinib",
"definition" : "L01EA01 - imatinib"
},
{
"code" : "L01EA02",
"display" : "dasatinib",
"definition" : "L01EA02 - dasatinib"
},
{
"code" : "L01EA03",
"display" : "nilotinib",
"definition" : "L01EA03 - nilotinib"
},
{
"code" : "L01EA04",
"display" : "bosutinib",
"definition" : "L01EA04 - bosutinib"
},
{
"code" : "L01EA05",
"display" : "ponatinib",
"definition" : "L01EA05 - ponatinib"
},
{
"code" : "L01EA06",
"display" : "Asciminib",
"definition" : "L01EA06 - Asciminib"
}
]
},
{
"code" : "L01EB",
"display" : "Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors",
"definition" : "L01EB - Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors"
},
{
"code" : "L01EH",
"display" : "Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors",
"definition" : "L01EH - Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors"
},
{
"code" : "L01EJ",
"display" : "Janus-associated kinase (JAK) inhibitors",
"definition" : "Janus associerede kinase (JAK) hæmmere",
"concept" : [
{
"code" : "L01EJ01",
"display" : "ruxolitinib",
"definition" : "L01EJ01 - ruxolitinib"
}
]
},
{
"code" : "L01EK",
"display" : "Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors",
"definition" : "L01EK - Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors"
},
{
"code" : "L01EL01",
"display" : "ibrutinib",
"definition" : "L01EL01 - ibrutinib"
},
{
"code" : "L01EL02",
"display" : "acalabrutinib",
"definition" : "L01EL02 - acalabrutinib"
},
{
"code" : "L01EM01",
"display" : "idelalisib",
"definition" : "L01EM01 - idelalisib"
},
{
"code" : "L01EN",
"display" : "Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors",
"definition" : "L01EN - Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors"
},
{
"code" : "L01FA01",
"display" : "rituximab",
"definition" : "L01FA01 - rituximab"
},
{
"code" : "L01FA02",
"display" : "ofatumumab",
"definition" : "L01FA02 - ofatumumab"
},
{
"code" : "L01FA03",
"display" : "obinutuzumab",
"definition" : "L01FA03 - obinutuzumab"
},
{
"code" : "L01FC01",
"display" : "daratumumab",
"definition" : "L01FC01 - daratumumab"
},
{
"code" : "L01FC02",
"display" : "isatuximab",
"definition" : "L01FC02 - isatuximab"
},
{
"code" : "L01FD01",
"display" : "trastuzumab",
"definition" : "L01FD01 - Trastuzumab"
},
{
"code" : "L01FF",
"display" : "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors",
"definition" : "L01FF - PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors",
"concept" : [
{
"code" : "L01FF01",
"display" : "nivolumab",
"definition" : "L01FF01 - Nivolumab"
},
{
"code" : "L01FF02",
"display" : "pembrolizumab",
"definition" : "L01FF02 - Pembrolizumab"
}
]
},
{
"code" : "L01FG01",
"display" : "bevacizumab",
"definition" : "L01FG01 - Bevacizumab"
},
{
"code" : "L01FX05",
"display" : "brentuximab vedotin",
"definition" : "L01FX05 - brentuximab vedotin"
},
{
"code" : "L01FX08",
"display" : "elotuzumab",
"definition" : "L01FX08 - elotuzumab"
},
{
"code" : "L01FX14",
"display" : "polatuzumab vedotin",
"definition" : "L01FX14 - polatuzumab vedotin"
},
{
"code" : "L01XA01",
"display" : "cisplatin",
"definition" : "L01XA01 - Cisplatin"
},
{
"code" : "L01XA02",
"display" : "carboplatin",
"definition" : "L01XA02 - Carboplatin"
},
{
"code" : "L01XA03",
"display" : "oxaliplatin",
"definition" : "L01XA03 - Oxaliplatin"
},
{
"code" : "L01XG01",
"display" : "bortezomib",
"definition" : "L01XG01 - bortezomib"
},
{
"code" : "L01XG02",
"display" : "carfilzomib",
"definition" : "L01XG02 - carfilzomib"
},
{
"code" : "L01XG03",
"display" : "ixazomib",
"definition" : "L01XG03 - ixazomib"
},
{
"code" : "L01XH",
"display" : "Histone deacetylase (HDAC) inhibitors",
"definition" : "L01XH - Histone deacetylase (HDAC) inhibitors",
"concept" : [
{
"code" : "L01XH01",
"display" : "vorinostat",
"definition" : "L01XH01 - vorinostat"
},
{
"code" : "L01XH03",
"display" : "panobinostat",
"definition" : "L01XH03 - panobinostat"
}
]
},
{
"code" : "L01XX05",
"display" : "hydroxycarbamide",
"definition" : "L01XX05 - hydroxycarbamide"
},
{
"code" : "L01XX35",
"display" : "anagrelide",
"definition" : "L01XX35 - anagrelide"
},
{
"code" : "L01XX52",
"display" : "venetoclax",
"definition" : "L01XX52 - venetoclax"
},
{
"code" : "L03AB",
"display" : "Interferons",
"definition" : "L03AB - Interferons"
},
{
"code" : "L04A",
"display" : "IMMUNOSUPPRESSANTS",
"definition" : "L04A - IMMUNOSUPPRESSANTS",
"concept" : [
{
"code" : "L04AA",
"display" : "Selective immunosuppressants",
"definition" : "L04AA - Selective immunosuppressants",
"concept" : [
{
"code" : "L04AA34",
"display" : "alemtuzumab",
"definition" : "L04AA34 - alemtuzumab"
},
{
"code" : "L04AA40",
"display" : "cladribine",
"definition" : "L04AA40 - cladribine"
}
]
}
]
},
{
"code" : "L04AD01",
"display" : "ciclosporin",
"definition" : "L04AD01 - ciclosporin"
},
{
"code" : "L04AX02",
"display" : "thalidomide",
"definition" : "L04AX02 - thalidomide"
},
{
"code" : "L04AX04",
"display" : "lenalidomide",
"definition" : "L04AX04 - lenalidomide"
},
{
"code" : "L04AX06",
"display" : "pomalidomide",
"definition" : "L04AX06 - pomalidomide"
},
{
"code" : "M05BA03",
"display" : "pamidronic acid",
"definition" : "M05BA03 - pamidronic acid"
},
{
"code" : "M05BA08",
"display" : "zoledronic acid",
"definition" : "M05BA08 - zoledronic acid"
},
{
"code" : "M05BX04",
"display" : "denosumab",
"definition" : "M05BX04 - denosumab"
},
{
"code" : "S01LA08",
"display" : "bevacizumab",
"definition" : "S01LA08 - Bevacizumab"
},
{
"code" : "V10X",
"display" : "OTHER THERAPEUTIC RADIOPHARMACEUTICALS",
"definition" : "V10X - OTHER THERAPEUTIC RADIOPHARMACEUTICALS",
"concept" : [
{
"code" : "V10XA53",
"display" : "tositumomab/iodine (131I) tositumomab",
"definition" : "V10XA53 - tositumomab/iodine (131I) tositumomab"
},
{
"code" : "V10XX02",
"display" : "ibritumomab tiuxetan (90Y)",
"definition" : "V10XX02 - ibritumomab tiuxetan (90Y)"
}
]
}
]
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.